**Core Concept**
Kala azar, also known as visceral leishmaniasis, is a severe form of leishmaniasis caused by the Leishmania parasite. The disease requires specific antiparasitic treatment to manage the infection effectively.

**Why the Correct Answer is Right**
The drug of choice for Kala azar is Miltefosine, an oral antileishmanial medication. Miltefosine works by inhibiting the growth of the Leishmania parasite, ultimately leading to its death. It is effective against both cutaneous and visceral leishmaniasis. Miltefosine is particularly useful for treating cases resistant to other antileishmanial drugs.

**Why Each Wrong Option is Incorrect**
**Option A:** The wrong option. This is because Miltefosine is the preferred treatment for Kala azar, not Amphotericin B.
**Option B:** This option is incorrect because Amphotericin B is used to treat visceral leishmaniasis, but it is not the first choice for Kala azar.
**Option C:** This option is incorrect because Pentavalent antimonials, such as Sodium stibogluconate, are used to treat visceral leishmaniasis but are not the preferred treatment for Kala azar due to increasing resistance.

**Clinical Pearl / High-Yield Fact**
It is essential to note that treatment for Kala azar should be tailored to the specific region, as resistance patterns can vary. Additionally, combination therapy with other antileishmanial drugs may be necessary for severe cases.

**Correct Answer: . Miltefosine**